SPEAKER: Day 1
Recent Techniques, Developments, Novel Strategies and Various Disciplines Involved in Drug Discovery
Dr. Tenaerts directs research to help identify, implement and make ubiquitous responsible decentralized trial strategies. Dr. Tenaerts brings more than 30 years of experience in clinical trials, as a researcher and academic, in medical device research operations, a hospital based site administrator, and physician, most recently serving as executive director of the Clinical Trials Transformation Initiative (CTTI) at Duke University. She sits on the board of the Society of Clinical trials, the Scientific Leadership Council of the Digital Medicine Society, participates on the Good Clinical Trial Collaborative, and is a member of the National Academies of Science and Medicine: Forum on drug discovery, development and translation. She received her MD from the Catholic University in Leuven and her MBA from the University of South Florida.